BIOMEDICAL EVIDENCE STRATEGY

Evidence. Insight. Action.

Invera BioMed translates complex biomedical evidence, biostatistics and real-world data into clear, actionable medical strategy.

For clinicians, researchers, medtech teams and biomedical innovators who need evidence to support better decisions.

Biomedical evidence • Biostatistics • Real-world data • Translational strategy

Biomedical innovation does not fail because data are missing. It often fails because evidence is difficult to interpret, difficult to implement, or disconnected from clinical reality.

Invera BioMed bridges the gap between data, evidence and implementation.

WHAT CHANGES

Clearer evidence

Turn complex clinical, biological and statistical information into evidence that can actually support decisions.

Better study thinking

Design studies, endpoints and analyses around the questions that matter clinically and strategically.

Stronger translation

Connect mechanisms, clinical reality and implementation pathways across research, medtech and medicine.

FOCUS AREAS

Where evidence meets decisions

Biomedical Evidence

Interpreting clinical and translational evidence with a focus on relevance, robustness and decision-making.

Biostatistics

Clear statistical thinking for study design, endpoints, sample size planning and interpretation.

Real-World Data

Turning routine clinical data, registries and observational evidence into usable insight.

Translational Strategy

Connecting biological mechanisms, clinical reality and implementation pathways in medicine and medtech.

THE FOUNDER

Founder-led biomedical evidence strategy

Invera BioMed was founded by Dr. Julian Rembe, clinician scientist, vascular surgeon and biomedical researcher working at the intersection of clinical medicine, wound healing, biostatistics and translational evidence.

His work focuses on making complex biomedical evidence understandable, usable and actionable — from clinical research and study design to real-world evidence and medtech strategy.

CLINICIAN SCIENTIST

Dr. Julian Rembe

Vascular surgeon · Biomedical researcher · Biostatistics & translational evidence

INVERA INSIGHTS

Complex concepts, made usable

Short, accessible articles on biostatistics, study design, real-world evidence and translational medical strategy. The goal is simple: make complex concepts easier to understand without oversimplifying what matters.

Biostatistics

4 min read

Confidence intervals explained without statistical fog

A practical explanation of what confidence intervals tell you, what they do not tell you, and why they often matter more than p-values.

Study Design

5 min read

Why sample size is a decision problem, not just a formula

Sample size is not only a statistical calculation. It reflects assumptions, uncertainty, feasibility and the decision a study is meant to support.

Clinical Endpoints

5 min read

What makes an endpoint clinically meaningful?

A good endpoint should measure something that matters to patients, clinicians, regulators or decision-makers.

Need evidence to support better biomedical decisions?

Invera BioMed helps translate complex data, clinical evidence and statistical reasoning into clear strategic direction.